“vertex-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Vertex Touts Positive Triple-Drug Data For Cystic Fibrosis Patients 07/18/17 Boston
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug 05/30/17 San Diego
Woodcock: New Approvals Show FDA Is Adapting to Precision Medicine 05/30/17 National
Shire Sets Sights on Dry Eye Disease with Deal for Parion Drug 05/01/17 Boston
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
First Trial in Sight, Editas Cuts $90M Eye Drug Deal With Allergan 03/14/17 Boston
Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More 03/10/17 National
Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics 03/08/17 Boston
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
Top Stories of 2016 for Xconomy Boston: Editor’s Picks 12/26/16 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Boston Healthtech Lab Links Startups with Hospitals, Bose, & Others 09/14/16 Boston
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion 09/14/16 Boston
From Art Collecting to Allego: Meet the Busiest CEO in Boston Tech 09/13/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Pronutria Rebrands as Axcella Health, Forms “Nutrition” Subsidiary 06/07/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Page 1 of 12 next page »